Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control

Timing of adjuvant CRT for resectable pancreatic cancer may not significantly affect LRC or OS. These findings support the ongoing RTOG 0848 trial design, and provide reassurance that delaying CRT until completion of chemotherapy should not significantly impact LRC.